As more CAD patients are considered for minimally invasive interventional therapy, optimal treatment planning is hindered by the fact that 2D coronary angiography has limitations for detecting and assessing coronary stenosis. Data is not consistently and meaningfully connected pre- and intra-procedure, which adds time and complexity to treatment planning. We’ve designed our cardiology solutions to overcome these challenges so you can realize the benefits of clinical efficiency in the cath lab. Philips conducted a new study that provides deeper insight into these challenges and how to address them by providing a powerful integrated network of solutions that enhance diagnostic reliability, decrease procedure times, improve staff experience, optimize performance, and ultimately ensure that clinicians are confident in their decision-making.
Image-guided therapy, iFR, IVUS and hemodynamic monitoring, as well as cardiac pre-procedure planning and advanced applications, are all connected to the image-guided therapy interface to allow viewing, manipulation, and custom configuration on the monitor from a single controller at table side or from the control room.
You are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
Continue* These products may not be for sale in your country. For availability, please consult your Sales Support desk for more information.
* These products may not be for sale in your country. For availability, please consult your Sales Support desk for more information.
1. Nannoni S, Strambo D, Sirimarco G, et al. Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center Journal of NeuroInterventional Surgery 2020;12:842-847.
2. Carolinas HealthCare System. Delivering the right stroke care faster. Philips Success Story. 2017.
3. Müller-Barna P, et al. TeleStroke Units Serving as a Model of Care in Rural Areas 10-Year Experience of the TeleMedical Project for Integrative Stroke Care.Stroke. 22014; 45(9): 2739-44.
*Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.
You are about to visit a Philips global content page
Continue